BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/14/2023 7:03:17 AM | Browse: 337 | Download: 1340
 |
Received |
|
2022-11-04 10:35 |
|
Peer-Review Started |
|
2022-11-04 10:36 |
|
First Decision by Editorial Office Director |
|
2022-12-13 08:53 |
|
Return for Revision |
|
2022-12-13 08:53 |
|
Revised |
|
2022-12-25 14:21 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-01-20 03:13 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-01-20 06:05 |
|
Articles in Press |
|
2023-01-20 06:05 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-02-03 07:55 |
|
Publish the Manuscript Online |
|
2023-02-14 07:03 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Urology & Nephrology |
| Manuscript Type |
Case Report |
| Article Title |
Bladder preservation in complicated invasive urothelial carcinoma following treatment with cisplatin/gemcitabine plus tislelizumab: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Rui Yang, Jun-Xing Chen, Shu-Hang Luo, Ting-Ting Chen, Ling-Wu Chen and Bin Huang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Bin Huang, MD, PhD, Doctor, Doctor, Department of Urology, The First Affiliated Hospital of Sun Yat-Sen University, No. 58 Zhong Shan 2nd Road, Guangzhou 510080, Guangdong Province, China. huangb48@mail.sysu.edu.cn |
| Key Words |
Invasive urothelial carcinoma; Immunotherapy; Chemotherapy; Squamous and glandular differentiation; Tislelizumab; Case report |
| Core Tip |
Urothelial carcinoma (UC) with complicated differentiation is highly malignant, and radical cystectomy (RC) is the preferred treatment. Because of the complications related to RC, bladder-sparing therapy has become a research hotspot. We here report a patient who was diagnosed with muscle-invasive bladder cancer with squamous and glandular differentiation and positive programmed cell death-ligand 1 (PD-L1) expression. The patient received a combination of chemotherapy and immunotherapy and achieved bladder preservation and has maintained tumor-free for over two years. This case highlights that the combination treatment might be an effective and safe strategy for UC with divergent histologic differentiation and positive PD-L1 expression. |
| Publish Date |
2023-02-14 07:03 |
| Citation |
Yang R, Chen JX, Luo SH, Chen TT, Chen LW, Huang B. Bladder preservation in complicated invasive urothelial carcinoma following treatment with cisplatin/gemcitabine plus tislelizumab: A case report. World J Clin Cases 2023; 11(5): 1165-1174 |
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i5/1165.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i5.1165 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
